(1)
To Evaluate The Use Of Ivabradine In Prevention Of Hemodynamic Response To Laryngoscopy And Intubation. Journal of Pharmaceutical Negative Results 2023, 388-398. https://doi.org/10.47750/pnr.2023.14.04.47.